Comparison of Coronary Xience V and the Cypher Select+ Stents in Diabetic Patients

Odense University Hospital150 enrolled

Overview

In stent neointimal hyperplasia may be less in the Cypher select plus stent compared to the Xience V stent in diabetic patients.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

SINGLE

Enrollment

150

Conditions

Diabetes Mellitus

Interventions

Cypher Select plusDEVICE

Drug eluting stent

Xience V stentDEVICE

Drug eluting stent

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * All diabetic patients treated with one or more drug eluting stents in the coronary arteries at one of the 5 heart centres in Denmark (Gentofte, Rigshospitalet, Odense, Skejby, Aalborg) can be included in the study. Exclusion Criteria: * The patient will not participate * The patient participates in other randomised stent studies * Expected survival \< 1 year * Allergy to Aspirin, Clopidogrel or Ticlopidine * Allergy to Sirolimus or ABT-578

Locations (1)

Odense University Hospital

Odense, Denmark

Outcomes

Primary Outcomes

In stent neointimal hyperplasia

Time frame: Within 10 months

Secondary Outcomes

Peri-stent remodeling - Edge response to Cypher Select plus and Xience V stent - Malapposition - Angiographic late lumen loss

Time frame: Within 10 months

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.